Bayer Thrombosis drug Asundexian shows positive study result Ruchika Sharma5 April 2022 10:00 AM ISTAsundexian is a so-called factor 11a inhibitor and was being compared to a drug sold under the brand name Eliquis by Pfizer and Bristol-Myers Squibb...
Bayer to set up 27 Telemedicine Centres in 12 districts across 8 States in India MD Bureau1 April 2022 2:27 PM ISTBayer will be setting up 27 telemedicine centres in 12 districts across 8 states with implementing partners Telerad RxDx and Piramal Swasthya
Bayer gets nod for Kerendia to treat type 2 diabetes, CKD in Japan Ruchika Sharma1 April 2022 9:00 AM ISTBerlin: Bayer has recently announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has granted marketing authorization for...
Bayer applies in EU for extension of Indication to Finerenone MD Bureau20 March 2022 1:00 PM ISTThe submission is based on positive data from the FIGARO-DKD study, which demonstrated that finerenone significantly reduced the risk of...
Pfizer, Bayer to maintain essential drug supply to Russia MD Bureau16 March 2022 3:44 PM ISTPfizer Inc and Bayer said on Monday they would maintain humanitarian supply of medicines to Russia, but would pull back from other non-essential...
Bayer Submits Application for NUBEQA to USFDA and EMA MD Bureau12 March 2022 2:45 PM ISTBayer today announced the submission of a supplemental new drug application to the U.S. Food and Drug Administration USFDA as well as the submission...
Bayer lifts peak sales estimate for prostate cancer drug Nubeqa : Report Ruchika Sharma18 Feb 2022 10:00 AM ISTFrankfurt: A therapy mix including Bayer's Nubeqa drug was shown to significantly prolong the lives of men suffering from metastatic prostate cancer...
Bayer bags USFDA Fast Track Designation for asundexian Stroke Program Ruchika Sharma11 Feb 2022 1:10 PM ISTBerlin: Bayer has recently announced that the U.S. Food and Drug Administration (USFDA) has granted Fast Track Designation for its investigational...
Bayer enhances leadership roles for D Narain, Simon Thorsten Wiebusch Ruchika Sharma11 Jan 2022 1:31 PM ISTNew Delhi: Global pharma and chemicals major Bayer on Monday said it has enhanced leadership roles for two senior executives from India team — D...
Jury rules in favour of Bayer Roundup case Ruchika Sharma7 Oct 2021 1:34 PM ISTBayer wins its first Roundup jury verdict in case of child's cancer
Bayer recalls Lotrimin, Tinactin antifungal sprays citing carcinogen contamination Ruchika Sharma4 Oct 2021 4:15 PM ISTWhippany: Bayer has recently announced that the company is voluntarily recalling all unexpired Lotrimin AF and Tinactin spray products with lot...
Bayer loses another appeal against Roundup cancer verdict Ruchika Sharma11 Aug 2021 12:55 PM ISTSan Francisco: German pharmaceutical and chemical giant Bayer on Monday lost another appeal against a verdict that found its Roundup weedkiller causes...
